Cipla to market Roche’s antibody cocktail pan-India, first batch currently available
Casirivimab and Imdevimab is indicated for restricted use in emergency situation for the treatment of mild to moderate COVID-19 in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
antibody cocktail
Roche’s antibody cocktail for COVID-19 may face affordability issues in India: GlobalData
Considering that it is a combination of two recombinant human immunoglobulin G-1 (IgG1) monoclonal antibodies, it is expected to…
Monoclonal antibodies against COVID-19 have high potential, but efficacy against emerging variants…
The prevalence of more transmissible strains is growing fast and may require adjustments to current therapies to ensure they…
AstraZeneca to supply 500,000 additional doses of COVID-19 antibody cocktail to US
The drugmaker said the $205 million US extension for 500,000 antibody doses builds on a contract agreed with government agencies…
Celltrion develops neutralising antibody cocktail to tackle COVID-19 variant spread
CT-P59 demonstrated neutralising capability against key emerging mutations, including the UK variant in addition to six variant…
AstraZeneca begins trials on antibody cocktail to prevent COVID-19
The prophylactic treatment may prove useful in people whose immune systems are weaker or compromised, and who don’t respond to…